Hwang Injoo, Lee Eun Ju, Park Hyomin, Moon Dodam, Kim Hyo-Soo
Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Republic of Korea.
Biomedical Research Institute, Seoul National University Hospital, 101 DeaHak-ro, JongRo-gu, Seoul, 03080, Republic of Korea.
Cell Biosci. 2021 Jan 6;11(1):3. doi: 10.1186/s13578-020-00509-w.
Hepatic stellate cells (HSCs) are activated in response to liver injury with TIF1γ-suppression, leading to liver fibrosis. Here, we examined the mechanism how reduction of TIF1γ in HSCs induces damage on hepatocytes and liver fibrosis.
Lrat:Cas9-ERT2:sgTif1γ mice were treated Tamoxifen (TMX) or wild-type mice were treated Thioacetamide (TAA). HSCs were isolated from mice liver and analyzed role of Tif1γ. HepG2 were treated retinol with/without siRNA for Stimulated by retinoic acid 6 (STRA6) or Retinoic acid receptor(RAR)-antagonist, and LX2 were treated siTIF1γ and/or siSTRA6. TAA treated mice were used for evaluation of siSTRA6 effect in liver fibrosis.
When we blocked the Tif1γ in HSCs using Lrat:Cas9-ERT2:sgTif1γ mice, retinol is distributed into hepatocytes. Retinol influx was confirmed using HepG2, and the increased intracellular retinol led to the upregulation of lipogenesis-related-genes and triglyceride. This effect was inhibited by a RAR-antagonist or knock-down of STRA6. In the LX2, TIF1γ-suppression resulted in upregulation of STRA6 and retinol release, which was inhibited by STRA6 knock-down. The role of STRA6-mediated retinol transfer from HSCs to hepatocytes in liver fibrosis was demonstrated by in vivo experiments where blocking of STRA6 reduced fibrosis.
Retinol from HSCs via STRA6 in response to injury with TIF1γ-reduction is taken up by hepatocytes via STRA6, leading to fat-deposition and damage, and liver fibrosis.
肝星状细胞(HSCs)在TIF1γ受抑制的情况下因肝损伤而被激活,进而导致肝纤维化。在此,我们研究了肝星状细胞中TIF1γ减少诱导肝细胞损伤和肝纤维化的机制。
用他莫昔芬(TMX)处理Lrat:Cas9-ERT2:sgTif1γ小鼠,或用硫代乙酰胺(TAA)处理野生型小鼠。从小鼠肝脏中分离肝星状细胞并分析Tif1γ的作用。用视黄醇处理HepG2细胞,同时给予或不给予针对视黄酸刺激6(STRA6)或视黄酸受体(RAR)拮抗剂的小干扰RNA(siRNA),并用siTIF1γ和/或siSTRA6处理LX2细胞。用TAA处理的小鼠用于评估siSTRA6在肝纤维化中的作用。
当我们使用Lrat:Cas9-ERT2:sgTif1γ小鼠阻断肝星状细胞中的Tif1γ时,视黄醇会分布到肝细胞中。利用HepG2细胞证实了视黄醇的流入,细胞内视黄醇的增加导致脂肪生成相关基因和甘油三酯上调。这种作用被RAR拮抗剂或STRA6基因敲低所抑制。在LX2细胞中,TIF1γ抑制导致STRA6上调和视黄醇释放,而STRA6基因敲低可抑制这一过程。体内实验证明了STRA6介导的视黄醇从肝星状细胞向肝细胞的转移在肝纤维化中的作用,即阻断STRA6可减轻纤维化。
肝星状细胞中因TIF1γ减少而产生的视黄醇通过STRA6响应损伤,被肝细胞通过STRA6摄取,导致脂肪沉积和损伤以及肝纤维化。